HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Millar, J. S. Articles by Schaefer, E. J. Search for Related Content PubMed PubMed Citation Articles by Millar, J. S. Articles by Schaefer, E. J. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 36, 1155-1167, Copyright © 1995 by Lipid Research, Inc.

ARTICLES

Impact of age on the metabolism of VLDL, IDL, and LDL apolipoprotein B- 100 in men

JS Millar, AH Lichtenstein, M Cuchel, GG Dolnikowski, DL Hachey, JS Cohn and EJ Schaefer
Lipid Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA 02111, USA.

Levels of plasma very low density lipoprotein (VLDL) and low density lipoprotein (LDL) constituents increase with age. In an attempt to further define the mechanisms responsible for these changes, kinetic studies of VLDL and LDL apolipoprotein (apo) B-100 were carried out in 19 normolipidemic male subjects with plasma total cholesterol and triglyceride levels below the 90th percentile whose ages ranged from 24 to 73 years. Subjects were maintained on standardized diets consisting of 47-49% of calories as carbohydrate, 15% protein, and 36-40% fat (15- 17% saturated, 15-17% monounsaturated, 6% polyunsaturated) with 150 mg cholesterol/1000 kcal. At the end of the diet period, the metabolism of apoB-100 within VLDL, intermediate density lipoprotein (IDL), and LDL was studied in the fed state using a primed-constant infusion of [2H3]leucine. Data were fit to a multicompartmental model to determine residence times and production rates of apoB-100 in each fraction. There were significant positive correlations between age and VLDL, IDL, and LDL apoB-100 concentrations (r = 0.50, 0.62, and 0.69; P = 0.03, 0.004, and 0.001, respectively). There was a positive correlation between age and the production rate of VLDL apoB-100 (r = 0.50, P = 0.03), but there was no significant relationship between age and either IDL or LDL apoB-100 production rates. Age was also positively correlated with the residence time of LDL apoB-100 (r = 0.68 P = 0.001). Our data suggest that the age-associated increase in VLDL apoB- 100 is due to an increased production rate of this constituent, whereas the age-associated increase in LDL apoB-100 is due to an increased residence time of these particles in plasma.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. S. Millar, M. E. Brousseau, M. R. Diffenderfer, P. Hugh, R. Barrett, F. K. Welty, A. Faruqi, M. L. Wolfe, C. Nartsupha, A. G. Digenio, et al. Effects of the Cholesteryl Ester Transfer Protein Inhibitor Torcetrapib on Apolipoprotein B100 Metabolism in Humans Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1350 - 1356. [Abstract] [Full Text] [PDF]

				S. Lamon-Fava, B. Postfai, M. Diffenderfer, C. DeLuca, J. O'Connor Jr, F. K. Welty, G. G. Dolnikowski, P. H. R. Barrett, and E. J. Schaefer Role of the Estrogen and Progestin in Hormonal Replacement Therapy on Apolipoprotein A-I Kinetics in Postmenopausal Women Arterioscler. Thromb. Vasc. Biol., February 1, 2006; 26(2): 385 - 391. [Abstract] [Full Text] [PDF]

				K. Ikewaki, J. R. Schaefer, M. E. Frischmann, K. Okubo, T. Hosoya, S. Mochizuki, B. Dieplinger, E. Trenkwalder, H. Schweer, F. Kronenberg, et al. Delayed In Vivo Catabolism of Intermediate-Density Lipoprotein and Low-Density Lipoprotein in Hemodialysis Patients as Potential Cause of Premature Atherosclerosis Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2615 - 2622. [Abstract] [Full Text] [PDF]

				F. K. Welty, A. H. Lichtenstein, P. H. R. Barrett, G. G. Dolnikowski, and E. J. Schaefer Interrelationships Between Human Apolipoprotein A-I and Apolipoproteins B-48 and B-100 Kinetics Using Stable Isotopes Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1703 - 1707. [Abstract] [Full Text] [PDF]

				R. D. Santos, W. Hueb, A. A. Oliveira, J. A. F. Ramires, and R. C. Maranhao Plasma kinetics of a cholesterol-rich emulsion in subjects with or without coronary artery disease J. Lipid Res., March 1, 2003; 44(3): 464 - 469. [Abstract] [Full Text] [PDF]

				F. Pont, L. Duvillard, E. Florentin, P. Gambert, and B. Verges Early Kinetic Abnormalities of ApoB-Containing Lipoproteins in Insulin-Resistant Women With Abdominal Obesity Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1726 - 1732. [Abstract] [Full Text] [PDF]

				E. J Schaefer Lipoproteins, nutrition, and heart disease Am. J. Clinical Nutrition, February 1, 2002; 75(2): 191 - 212. [Abstract] [Full Text] [PDF]

				H. Relas, H. Gylling, R. A. Rajaratnam, and T. A. Miettinen Postprandial Retinyl Palmitate and Squalene Metabolism Is Age Dependent J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2000; 55(11): 515B - 521. [Abstract] [Full Text]

				F. K. Welty, A. H. Lichtenstein, P. H. R. Barrett, G. G. Dolnikowski, and E. J. Schaefer Human Apolipoprotein (Apo) B-48 and ApoB-100 Kinetics With Stable Isotopes Arterioscler. Thromb. Vasc. Biol., December 1, 1999; 19(12): 2966 - 2974. [Abstract] [Full Text] [PDF]

				P. Parini, B. Angelin, and M. Rudling Cholesterol and Lipoprotein Metabolism in Aging : Reversal of Hypercholesterolemia by Growth Hormone Treatment in Old Rats Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 832 - 839. [Abstract] [Full Text] [PDF]

				F. Pont, L. Duvillard, B. Verges, and P. Gambert Development of Compartmental Models in Stable-Isotope Experiments : Application to Lipid Metabolism Arterioscler. Thromb. Vasc. Biol., June 1, 1998; 18(6): 853 - 860. [Abstract] [Full Text] [PDF]

				H. Zulewski, R. Ninnis, A. R. Miserez, M. W. Baumstark, and U. Keller VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100 J. Lipid Res., February 1, 1998; 39(2): 380 - 387. [Abstract] [Full Text]

				M. Cuchel, E. J. Schaefer, J. S. Millar, P. J.H. Jones, G. G. Dolnikowski, C. Vergani, and A. H. Lichtenstein Lovastatin Decreases De Novo Cholesterol Synthesis and LDL Apo B-100 Production Rates in Combined-Hyperlipidemic Males Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 1910 - 1917. [Abstract] [Full Text]